These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 30670682

  • 1. Septin filament coalignment with microtubules depends on SEPT9_i1 and tubulin polyglutamylation, and is an early feature of acquired cell resistance to paclitaxel.
    Targa B, Klipfel L, Cantaloube I, Salameh J, Benoit B, Poüs C, Baillet A.
    Cell Death Dis; 2019 Jan 22; 10(2):54. PubMed ID: 30670682
    [Abstract] [Full Text] [Related]

  • 2. Septin cooperation with tubulin polyglutamylation contributes to cancer cell adaptation to taxanes.
    Froidevaux-Klipfel L, Targa B, Cantaloube I, Ahmed-Zaïd H, Poüs C, Baillet A.
    Oncotarget; 2015 Nov 03; 6(34):36063-80. PubMed ID: 26460824
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Expression of the SEPT9_i4 isoform confers resistance to microtubule-interacting drugs.
    Chacko AD, McDade SS, Chanduloy S, Church SW, Kennedy R, Price J, Hall PA, Russell SE.
    Cell Oncol (Dordr); 2012 Apr 03; 35(2):85-93. PubMed ID: 22278362
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Regulation of microtubule plus end dynamics by septin 9.
    Nakos K, Rosenberg M, Spiliotis ET.
    Cytoskeleton (Hoboken); 2019 Jan 03; 76(1):83-91. PubMed ID: 30144301
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mitotic centromere-associated kinesin (MCAK) mediates paclitaxel resistance.
    Ganguly A, Yang H, Pedroza M, Bhattacharya R, Cabral F.
    J Biol Chem; 2011 Oct 21; 286(42):36378-84. PubMed ID: 21903575
    [Abstract] [Full Text] [Related]

  • 9. Microtubule-binding protein CLIP-170 is a mediator of paclitaxel sensitivity.
    Sun X, Li D, Yang Y, Ren Y, Li J, Wang Z, Dong B, Liu M, Zhou J.
    J Pathol; 2012 Mar 21; 226(4):666-73. PubMed ID: 21989536
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Molecular dynamics simulation and free energy landscape methods in probing L215H, L217R and L225M βI-tubulin mutations causing paclitaxel resistance in cancer cells.
    Tripathi S, Srivastava G, Sharma A.
    Biochem Biophys Res Commun; 2016 Aug 05; 476(4):273-279. PubMed ID: 27233604
    [Abstract] [Full Text] [Related]

  • 13. New microtubule/tubulin-targeted anticancer drugs and novel chemotherapeutic strategies.
    Wilson L, Jordan MA.
    J Chemother; 2004 Nov 05; 16 Suppl 4():83-5. PubMed ID: 15688618
    [Abstract] [Full Text] [Related]

  • 14. BetaIII-tubulin induces paclitaxel resistance in association with reduced effects on microtubule dynamic instability.
    Kamath K, Wilson L, Cabral F, Jordan MA.
    J Biol Chem; 2005 Apr 01; 280(13):12902-7. PubMed ID: 15695826
    [Abstract] [Full Text] [Related]

  • 15. Accompanying protein alterations in malignant cells with a microtubule-polymerizing drug-resistance phenotype and a primary resistance mechanism.
    Poruchynsky MS, Giannakakou P, Ward Y, Bulinski JC, Telford WG, Robey RW, Fojo T.
    Biochem Pharmacol; 2001 Dec 01; 62(11):1469-80. PubMed ID: 11728383
    [Abstract] [Full Text] [Related]

  • 16. Mammalian SEPT9 isoforms direct microtubule-dependent arrangements of septin core heteromers.
    Sellin ME, Stenmark S, Gullberg M.
    Mol Biol Cell; 2012 Nov 01; 23(21):4242-55. PubMed ID: 22956766
    [Abstract] [Full Text] [Related]

  • 17. Mutations in alpha- and beta-tubulin that stabilize microtubules and confer resistance to colcemid and vinblastine.
    Hari M, Wang Y, Veeraraghavan S, Cabral F.
    Mol Cancer Ther; 2003 Jul 01; 2(7):597-605. PubMed ID: 12883031
    [Abstract] [Full Text] [Related]

  • 18. Mutations at leucine 215 of beta-tubulin affect paclitaxel sensitivity by two distinct mechanisms.
    Wang Y, Yin S, Blade K, Cooper G, Menick DR, Cabral F.
    Biochemistry; 2006 Jan 10; 45(1):185-94. PubMed ID: 16388594
    [Abstract] [Full Text] [Related]

  • 19. Bcl-xL is phosphorylated in malignant cells following microtubule disruption.
    Poruchynsky MS, Wang EE, Rudin CM, Blagosklonny MV, Fojo T.
    Cancer Res; 1998 Aug 01; 58(15):3331-8. PubMed ID: 9699663
    [Abstract] [Full Text] [Related]

  • 20. Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells.
    Wang H, Vo T, Hajar A, Li S, Chen X, Parissenti AM, Brindley DN, Wang Z.
    BMC Cancer; 2014 Jan 22; 14():37. PubMed ID: 24447372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.